Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

by Lori SolomonOutcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over t

Updated on: February 18,2024

Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

by Lori SolomonOutcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over t

Updated on:February 18,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on: May 31,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on:May 31,2024

Drug hobbles deadly liver cancer by stifling protein production

by University of California, San FranciscoCredit: CC0 Public DomainIn laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a su

Updated on: May 25,2024

Drug hobbles deadly liver cancer by stifling protein production

by University of California, San FranciscoCredit: CC0 Public DomainIn laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a su

Updated on:May 25,2024

COVID reforms in cancer care and research could have long-term benefits

by King's College LondonCredit: Unsplash/CC0 Public DomainA new review led by Professor James Spicer considers the reforms in cancer care and research made due to the pandemic, arguing that s

Updated on: January 29,2024

COVID reforms in cancer care and research could have long-term benefits

by King's College LondonCredit: Unsplash/CC0 Public DomainA new review led by Professor James Spicer considers the reforms in cancer care and research made due to the pandemic, arguing that s

Updated on:January 29,2024

Researchers define mechanism that causes kidney cancer to recur

by University of Texas Health Science Center at San AntonioNew research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans A

Updated on: June 08,2024

Researchers define mechanism that causes kidney cancer to recur

by University of Texas Health Science Center at San AntonioNew research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans A

Updated on:June 08,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on: March 01,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on:March 01,2024

Technique targets cancer cells and leaves healthy ones alone

by Hebrew University of JerusalemTRPV2 protein in action. Credit: Hebrew University of JerusalemIt is a feeling that many who receive a cancer diagnosis can identify with: heartbreak and fear, fo

Updated on: April 18,2024

Technique targets cancer cells and leaves healthy ones alone

by Hebrew University of JerusalemTRPV2 protein in action. Credit: Hebrew University of JerusalemIt is a feeling that many who receive a cancer diagnosis can identify with: heartbreak and fear, fo

Updated on:April 18,2024

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on: February 23,2024

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on:February 23,2024

Research advances to better target debilitating effects of cachexia syndrome

by Medical University of South CarolinaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study published inCell ReportsAug.

Updated on: June 28,2024

Research advances to better target debilitating effects of cachexia syndrome

by Medical University of South CarolinaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study published inCell ReportsAug.

Updated on:June 28,2024

Researchers search for solutions to 'invisible threat' that affects cancer care workers

by University of MichiganVisual abstracts describes the study's findings. Credit: University of Michigan School of NursingChemotherapy drugs are lifesaving to cancer patients, but these toxic

Updated on: June 01,2024

Researchers search for solutions to 'invisible threat' that affects cancer care workers

by University of MichiganVisual abstracts describes the study's findings. Credit: University of Michigan School of NursingChemotherapy drugs are lifesaving to cancer patients, but these toxic

Updated on:June 01,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on: January 02,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on:January 02,2024

Generating large numbers of universal immune cells could transform cancer immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeA novel method to generate natural killer cells from peripheral blood cell-derived stem cells may transform immunotherapies for d

Updated on: March 12,2024

Generating large numbers of universal immune cells could transform cancer immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeA novel method to generate natural killer cells from peripheral blood cell-derived stem cells may transform immunotherapies for d

Updated on:March 12,2024